Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Mesoblast Limited MESO

Full chart Compare

Set alert

13.99 USD -0.45 (-3.12%)

At closeNov 10, 2026, 4:00 PM EST

13.99 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

13.85 Day range 14.30

11.89 52-week range 21.50

YTD: -22.45%
1 year: -8.02%

News

6 days ago globenewswire.com Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it hosted a key opinion…
1 week ago benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75%…
1 week ago benzinga.com Why Glaukos Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket Glaukos surged 17.4% premarket after strong Q3 results and raised FY26 sales guidance; INLF, NCPL and PCLA also rallied.